Fiscal year ending 2023. Filed on February 21, 2024.
2425 Ridgecrest Drive SE
Albuquerque, New Mexico 87108
Lovelace Biomedical Research Institute (EIN: 85-0110669) has filed an IRS Form 990 between fiscal years 2017 and 2024. In its fiscal year 2023 IRS Form 990 filing, Lovelace Biomedical Research Institute, a 501(c)(3) charitable organization, reported compensation for 9 out of 503 total employees. Among the employees shown here, the average compensation is $567,088. The highest compensated employee at Lovelace Biomedical Research Institute is Alan Kadish President with fiscal year 2023 compensation of $1,309,613.
Revenue
Expenses
Employee compensation
THE LOVELACE BIOMEDICAL RESEARCH INSTITUTE (LBRI) IS A PRIVATE, BIOMEDICAL RESEARCH ORGANIZATION DEDICATED TO IMPROVING PUBLIC HEALTH THROUGH RESEARCH ON THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF DISEASES. LBRI IS DEDICATED TO THE DISCOVERY AND ADVANCEMENT OF CLINICAL SOLUTIONS FOR PREVENTION, DIAGNOSIS, TREATMENT AND CURING DISEASES THROUGH RESEARCH. THE RESEARCH IS AIMED AT UNDERSTANDING THEIR CAUSES AND BIOLOGICAL MECHANISMS; ASSESSING AND ELIMINATING EXPOSURES TO RESPIRATORY, NEUROLOGICAL AND OTHER HEALTH HAZARDS; MENTAL ILLNESS; TRAUMATIC BRAIN INJURY AND OTHER BRAIN DISORDERS; AND DEVELOPING IMPROVED THERAPEUTICS, VACCINES, AND DIAGNOSTICS. LBRI IS BASED IN ALBUQUERQUE, NEW MEXICO.
Be the first to know when new IRS Form 990 data is published for this organization.